A detailed history of Victory Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 2,106,117 shares of ABBV stock, worth $361 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
2,106,117
Previous 1,954,892 7.74%
Holding current value
$361 Million
Previous $303 Million 26.6%
% of portfolio
0.39%
Previous 0.33%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$159.82 - $182.1 $24.2 Million - $27.5 Million
151,225 Added 7.74%
2,106,117 $384 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $33.2 Million - $37.4 Million
241,237 Added 14.08%
1,954,892 $303 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $299,241 - $346,416
2,240 Added 0.13%
1,713,655 $255 Million
Q2 2023

Jul 27, 2023

SELL
$132.51 - $164.9 $6.41 Million - $7.98 Million
-48,371 Reduced 2.75%
1,711,415 $231 Million
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $68.6 Million - $79 Million
-474,598 Reduced 21.24%
1,759,786 $280 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $3.43 Million - $4.12 Million
24,820 Added 1.12%
2,234,384 $361 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $7.58 Million - $9.09 Million
-54,775 Reduced 2.42%
2,209,564 $357 Million
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $14.6 Million - $16.8 Million
-109,094 Reduced 4.6%
2,264,339 $304 Million
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $57.9 Million - $73.7 Million
-421,047 Reduced 15.07%
2,373,433 $364 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $25.9 Million - $32.1 Million
196,208 Added 7.55%
2,794,480 $422 Million
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $24.9 Million - $31.5 Million
231,399 Added 9.78%
2,598,272 $352 Million
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $26.8 Million - $30.4 Million
251,631 Added 11.9%
2,366,873 $255 Million
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $55.3 Million - $61.6 Million
525,266 Added 33.04%
2,115,242 $238 Million
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $11.8 Million - $13 Million
115,412 Added 7.83%
1,589,976 $172 Million
Q4 2020

Feb 01, 2021

SELL
$80.49 - $108.67 $3.03 Million - $4.09 Million
-37,599 Reduced 2.49%
1,474,564 $158 Million
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $1.75 Million - $2.05 Million
-20,380 Reduced 1.33%
1,512,163 $132 Million
Q2 2020

Aug 07, 2020

SELL
$73.37 - $98.18 $22.9 Million - $30.7 Million
-312,195 Reduced 16.92%
1,532,543 $150 Million
Q1 2020

May 04, 2020

SELL
$64.5 - $97.79 $38.6 Million - $58.6 Million
-598,901 Reduced 24.51%
1,844,738 $141 Million
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $45 Million - $56.3 Million
623,599 Added 34.26%
2,443,639 $216 Million
Q4 2019

Feb 04, 2020

SELL
$72.13 - $90.25 $53.4 Million - $66.8 Million
-740,596 Reduced 28.92%
1,820,040 $147 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $124 Million - $149 Million
1,967,910 Added 332.01%
2,560,636 $194 Million
Q2 2019

Aug 15, 2019

BUY
$65.7 - $83.98 $30.1 Million - $38.5 Million
458,809 Added 342.61%
592,726 $43.1 Million
Q1 2019

May 03, 2019

SELL
$77.14 - $90.79 $14.2 Million - $16.8 Million
-184,559 Reduced 57.95%
133,917 $10.8 Million
Q4 2018

Feb 05, 2019

SELL
$77.85 - $96.01 $1.07 Million - $1.32 Million
-13,758 Reduced 4.14%
318,476 $29.4 Million
Q3 2018

Nov 01, 2018

BUY
$88.91 - $98.84 $15.2 Million - $16.9 Million
170,600 Added 105.55%
332,234 $31.4 Million
Q2 2018

Aug 02, 2018

BUY
$89.78 - $106.23 $10.6 Million - $12.5 Million
118,089 Added 271.19%
161,634 $15 Million
Q1 2018

May 04, 2018

SELL
$92.01 - $123.21 $12.7 Million - $17 Million
-138,079 Reduced 76.02%
43,545 $4.12 Million
Q4 2017

Feb 01, 2018

SELL
$89.56 - $98.21 $5.49 Million - $6.02 Million
-61,279 Reduced 25.23%
181,624 $17.6 Million
Q3 2017

Oct 27, 2017

BUY
$69.85 - $89.22 $4.88 Million - $6.24 Million
69,923 Added 40.42%
242,903 $21.6 Million
Q2 2017

Aug 07, 2017

BUY
N/A
172,980
172,980 $12.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.